James Coates Contributor James Coates is the Health and Human Performance principal at Decisive Point, a venture capital and advisory firm that invests in and supports startups with emerging defense […]
Biotech
Trending topics and news from the Biotech category
Back to news homeMeta Pharmaceuticals lands $15M to make autoimmune drugs with AI, new immuno-metabolism tech
Biotech startup Meta Pharmaceuticals sets itself an ambitious goal as it secures its initial investment. The Shenzhen-based company, which sets out to develop treatments for autoimmune diseases with the help […]
Isabl’s rapid whole-genome analysis opens the playbook for cancer treatment
Every cancer is unique because every person is unique, and one of the most important weapons in any cancer battle is information. Isabl offers that in abundance through rapid sequencing […]
Mayfield’s Arvind Gupta discusses startup fundraising during a downturn
Between his roles as co-leader of Mayfield Fund’s engineering biology practice and founder at IndieBio, Arvind Gupta reviewed approximately 470 startup pitches last year. He characterizes his process as “simple,” […]
Here’s Y Combinator’s answer to cultivated meat’s scaling problem
The positive impact alternative meat products – like plant-based meat or cultivated meat – can have on the environment is striking. In optimistic scenarios where we transition to from meat-laden […]
Sectors where New Zealand startups are poised to win
As a remote island nation in the middle of the South Pacific, New Zealand is experiencing the stirrings of a burgeoning startup scene. The country has historically been capital-starved, but […]
Phylagen, which tracks indoor microbiomes, says it’s right now “racing to meet demand”
Two years into a worldwide pandemic, outfits around the globe are wrestling with how to resume their in-person operations safely. Consider that Apple just scrapped its office-return deadline, while Google, […]
Primer Sazze Partners closes $127M second fund aimed at South Korean entrepreneurs
Primer Sazze Partners, a San Jose-based venture capital firm, announced today it has raised its second fund at $127 million (150 billion won) to invest in startups founded by Korean […]
Generate Biomedicines raises $370M Series B with a focus on protein-based drugs
The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round. Generate Biomedicines is touting […]
An accelerator and fund says it’s giving away its voting rights to scientist founders
SciFounders, an accelerator program and fund launched back in January with $6 million in backing, has a new proposition for the scientist founders who it looks to help run their […]